Natural stimulus responsive scaffolds/cells for bone tissue engineering : influence of lysozyme upon scaffold degradation and osteogenic differentiation of cultured marrow stromal cells induced by CaP coatings by Martins, Ana M. et al.
Original Article
Natural Stimulus Responsive Scaffolds=Cells
for Bone Tissue Engineering: Influence of Lysozyme
upon Scaffold Degradation and Osteogenic Differentiation
of Cultured Marrow Stromal Cells Induced by CaP Coatings
Ana M. Martins, B.S.,1–3 Quynh P. Pham, Ph.D.,3 Patrı´cia B. Malafaya, Ph.D.,1,2
Robert M. Raphael, Ph.D.,3 F. Kurtis Kasper, Ph.D.,3
Rui L. Reis, Ph.D., D.Sc.,1,2 and Antonios G. Mikos, Ph.D.3
This work proposes the use of nonporous, smart, and stimulus responsive chitosan-based scaffolds for bone
tissue engineering applications. The overall vision is to use biodegradable scaffolds based on chitosan and starch
that present properties that will be regulated by bone regeneration, with the capability of gradual in situ pore
formation. Biomimetic calcium phosphate (CaP) coatings were used as a strategy to incorporate lysozyme at the
surface of chitosan-based materials with the main objective of controlling and tailoring their degradation profile
as a function of immersion time. To confirm the concept, degradation tests with a lysozyme concentration similar
to that incorporated into CaP chitosan-based scaffolds were used to study the degradation of the scaffolds and
the formation of pores as a function of immersion time. Degradation studies with lysozyme (1.5 g=L) showed the
formation of pores, indicating an increase of porosity (*5–55% up to 21 days) resulting in porous three-
dimensional structures with interconnected pores. Additional studies investigated the influence of a CaP
biomimetic coating on osteogenic differentiation of rat marrow stromal cells (MSCs) and showed enhanced
differentiation of rat MSCs seeded on the CaP-coated chitosan-based scaffolds with lysozyme incorporated.
At all culture times, CaP-coated chitosan-based scaffolds with incorporated lysozyme demonstrated greater
osteogenic differentiation of MSCs, bone matrix production, and mineralization as demonstrated by calcium
deposition measurements, compared with controls (uncoated scaffolds). The ability of these CaP-coated
chitosan-based scaffolds with incorporated lysozyme to create an interconnected pore network in situ coupled
with the demonstrated positive effect of these scaffolds upon osteogenic differentiation of MSCs and mineralized
matrix production illustrates the strong potential of these scaffolds for application in bone tissue engineering
strategies.
Introduction
Tissue engineering strategies include two general ca-tegories: (1) the use of acellular matrices (artificial scaf-
folds or decellularized tissues), which depend upon the
natural ability of the body to regenerate for proper orienta-
tion and direction of new tissue growth, and (2) the use of
scaffolds with cells.1,2 The typical strategy involves the use
of a porous scaffold, which serves as a transplantation
vehicle for cultured cells and a template to guide tissue re-
generation, thereby playing an important role in transform-
ing the cell-seeded scaffold into a new tissue. To allow a
high density of colonizing cells and to promote neovascu-
larization when implanted in vivo, the scaffolds should
have high porosity, large surface area, mechanical proper-
ties and pore sizes appropriate for the application, and
a highly interconnected pore structure.1 In addition, bio-
compatibility and biodegradability are also required prop-
erties. Bone regeneration is a complex series of events
involving proliferation and differentiation of mesenchymal
stem cells into osteoblasts, bone matrix production, and
mineralization.3
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As extensively described in the literature, scaffold porosity is
inversely related to the mechanical properties of the scaffold;
thus, it is necessary to balance the mechanical needs of the
particular tissue that is going to be replaced and the scaffold
porosity sufficient to allow tissue growth.4,5 Therefore, this
work proposes the use of nonporous scaffolds composed of an
in vivo responsive material that will be regulated by bone re-
generation,with gradual in situ pore formation and consequent
scaffold resorption.6 This novel approach includes the use of
smart and stimulus responsive scaffolds that might be intelli-
gent enough to control their degradation profile as a function of
implantation time and to induce osteogenic differentiation of
marrow stromal cells (MSCs).
Chitosan has been considered to be a promising material
for tissue engineering applications.7–9 It is a linear copoly-
mer of N-acetyl-D-glucosamine and D-glucosamine, derived
from the deacetylation of chitin. The deacetylation degree
measures the percentage of glucosamine units in the polymer
chain and influences its physicochemical properties such as
solubility, crystallinity, swelling behavior, and biological
properties,10 such as osteogenesis enhancement.11–13 The N-
acetylglucosamine present in chitosan is also responsible for
nitric oxide production by rat peritoneal exudate macro-
phages14 at reasonable levels in terms of inflammatory re-
sponse but very effective in terms of wound tissue repair.15 It
has also been demonstrated that chitosan is degraded in vitro
and in vivo by lysozyme,15–17 an enzyme ubiquitous in the
human body. Moreover, hydrolytic actions of lysozyme are
able to activate macrophages and to promote collagen de-
position. The biocompatibility of chitosan might be attrib-
uted to its structural similarity to glycosaminoglycan, which
is a major component of the extracellular matrix (ECM) of
bone and cartilage.12
Starch was used as a component of the scaffolds presented
in this study as a sacrifice material that will be easily de-
graded by several enzymes occurring in the human body.6
Several in vitro and in vivo studies have shown that starch-
based biomaterials are biocompatible18–20 and biodegrad-
able.6,21,22 The main enzymes involved in starch degradation
are a-amylases, b-amylases, a-glucosidases, glucoamylases,
and other debranching enzymes (pullulanase and iso-
amylase).23,24 The enzymatic degradation products of starch
hydrolysis are mainly glucose, maltose, and dextrin.24
A potential method to enhance the bone bonding, osteo-
conductive, and=or osteoinductive capacity of chitosan and
starch-based scaffolds is to apply on the surface of the three-
dimensional (3D) structures a calcium phosphate (CaP)
biomimetic coating with a composition similar to the major
inorganic component of bone, hydroxyapatite. In addition,
biomimetic CaP coatings have been considered as potential
carriers of bioactive proteins without compromising their
activity, as they are generated under physiological condi-
tions (pH 7.4, 378C).22,25–28 It has been shown that different
proteins can be directly integrated into the structure of CaP
coatings without compromising their activity, and their re-
lease is mainly controlled by the dissolution mechanism of
the coating.22,25–27 In this sense, biomimetic coatings were
used to tailor the material surface properties or to directly
enhance cell adhesion, proliferation, and osteogenic differ-
entiation. Moreover, CaP coatings are used as a means to
functionalize biomaterials with biological affinity and pro-
tein adsorption properties, as previously mentioned.28 The
incorporation of different enzymes into CaP coatings, pre-
pared on the surface of scaffolds by means of a biomimetic
coating technique, seems to be a very interesting strategy to
control their degradation rate. In this work, lysozyme was
incorporated into the coatings with the aim of developing a
self-regulating degradable material with a capacity for
gradual in situ pore formation. In addition, this system can
simultaneously exhibit osteoinductive and osteoconductive
properties in the sense that it can act as a carrier system for
the controlled release of multiple biologically active proteins.
In the past decade, a large number of publications showed
osteoinduction by CaP coatings in several animal mod-
els.29,30 Recent research has shown that the biological per-
formance of osteoinductive biomaterials, namely, on new
bone growth orthotopically, is significantly better than non-
osteoinductive biomaterials.30
The present study reports the use of CaP-coated chitosan-
based scaffolds with incorporated lysozyme. This study was
designed to answer the following questions: (1) How does
lysozyme influence the formation of pores in chitosan scaf-
folds, using a similar concentration to the one incorporated
into CaP coatings? (2) Does this concentration of lysozyme
allow the formation of interconnected pores? (3) Are CaP-
coated chitosan-based scaffolds able to enhance osteogenic
differentiation of rat MSCs compared with uncoated (with-
out CaP coating) scaffolds?
Materials and Methods
Materials
In this work, degradable scaffolds based on chitosan and
corn starch were developed. Two different compositions were
prepared using a precipitation method7: chitosan (Ch) and
chitosan=starch (CS) scaffolds. Briefly, chitosan was dissolved
in acetic acid 1% (v=v) to obtain a 5% (w=v) solution. Then,
using the same procedure, another formulation was prepared
with the following ratio: 60=40 chitosan=starch. The chitosan
and chitosan=starch solutions were cast into molds and frozen
(188C) overnight.6 They were then immersed in a precipita-
tion solution (25% (v) NaOH 1M and 75% (v) Na2SO4 0.5M)
overnight, adapted from Tuzlakoglu et al.7 After precipitation,
the samples were washed several times with distilled water to
remove excess salt from the precipitation solution. After this
procedure, two other formulations were prepared based on
biomimetic coating methodology,31,32 consisting of an im-
pregnation of the materials with bioactive glass called Bio-
glass (45S5) supplied by NovaMin Technology (Alachua, FL)
followed by an immersion in a simulated body fluid (SBF,
378C, pH7.4), presenting ionic concentrations similar to human
blood plasma. Briefly, chitosan (Ch) and chitosan=starch (CS)
scaffolds were immersed in a wet bed of bioglass for 6 h in a
rotator. After that, the scaffolds were immersed in simulated
body fluid (1.0 SBF) solution with lysozyme (1 g=L) for 7 days
at 378C (nucleation stage). This stage allows for the formation
of CaP nuclei. After the nucleation stage, all samples were
washed with distilled water and immersed in a concentrated
simulated body fluid solution (1.5 SBF) for 7 days at 378C to
enhance CaP nuclei growth. Two different samples were ob-
tained after the biomimetic coating technique: CaP chitosan
scaffolds with incorporated lysozyme (CaP=Chþ lysozyme)
and CaP chitosan=starch scaffolds with incorporated lysozyme
(CaP=CSþ lysozyme).33
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Degradation studies
Degradation studies were performed in triplicate by in-
cubating the chitosan scaffolds (Ch) in phosphate-buffered
saline (PBS) solution (pH 7.4) with lysozyme (1.5 g=L), a
concentration similar to the ones incorporated into CaP
biomimetic coatings, at 378C up to 21 days. Lysozyme so-
lution was changed every 7 days. At the end of the degra-
dation period, the samples were removed, washed with
distilled water, and dried in a graded series of ethanol for
later calculation of weight loss. The porosity, pore inter-
connectivity, pore size, and 3D structures of dry chitosan
scaffolds were analyzed before and after degradation by
microcomputed tomography (m-CT).
Microcomputed tomography
The scaffolds were analyzed using m-CT before and after
degradation with lysozyme for the different periods of im-
mersion (0, 3, 14, and 21 days). m-CT was carried out using a
Skyscan 1072 (Skyscan, Kontich, Belgium) (pixel size reso-
lution of 6.59 mm), with X-ray source settings of 40 keV and
250 mA. The data sets were acquired over a rotation range of
1808 (0.458 rotation step) and reconstructed with software
(NRecon v1.4.3; SkyScan). Representative data sets were
segmented with a dynamic threshold of 40-255 and were
used for morphometric analysis (CT Analyser, v1.5.1.5;
SkyScan) and to build the 3D models (ANT 3D creator, v2.4;
SkyScan). The morphometric analysis included porosity,
pore interconnectivity, mean pore size, and mean fiber
thickness. Three-dimensional virtual models of representa-
tive regions in the bulk of the scaffolds were created, visu-
alized, and registered using both image processing software
packages to access the morphological changes after degra-
dation (CT Analyser and ANT 3D creator). The inter-
connectivity was quantified as the accessible void fraction
over a range of minimum connection sizes using an analysis
software tool (CT Analyser, v1.5.1.5; SkyScan). A 3D shrink-
wrap process was performed to shrink the outside boundary
of the volume of interest (VOI) in a scaffold through any
openings whose size was equal to or larger than 53mm. Any
void space connected via interconnects below this size was
considered to be inaccessible,34 based upon reported mini-
mum pore interconnection sizes for bone tissue in-
growth.35,36 Interconnectivity was calculated as follows37:
Interconnectivity¼ (VtVsw)=(VtVm) · 100%
where Vt is the total volume of the VOI, Vsw is the VOI
volume after 3D shrink-wrap processing, and Vm is the
volume of scaffold material.
The wall thickness was defined as the pore wall thickness
and was quantified with m-CT analysis based upon structural
indices using a software tool (CT Analyser, v1.5.1.5; Sky-
Scan). Specifically, quantitative analysis of the pore wall
thickness was retrieved from the 3D analysis using structure
thickness parameters.
MSCs isolation
Rat MSCs were obtained from femurs and tibias of 41–
44-day-old male Wistar rats (Charles River Laboratories,
Wilmington, MA) using the method described by Maniato-
poulos et al.38 The harvested cells were cultured until con-
fluence in a humidified atmosphere with 5% CO2 at 378C.
Nonadherent cells were removed after 1 and 3 days. Upon
reaching confluence, the cells were trypsinized, centrifuged,
and resuspended in a known amount of medium and 10%
dimethyl sulfoxide to obtain a final concentration of
3106 cells=mL. This cell suspension was then aliquoted into
cryotubes for storage in liquid nitrogen (*1mL=cryotube).
Cell seeding
Chitosan-based scaffolds with 6mm diameter and thick-
ness of 0.8–1.0mm were press fit into 6-mm-diameter
cassettes and covered with complete osteogenic medium
[a-MEM supplemented with 10% fetal bovine serum from
Cambrex=BioWhittaker (Walkersville, MD), 50 mg=mL gen-
tamicin, 100mg=mL ampicilin, 10mM fungizone, 50 mg=mL
L-ascorbic acid, 0.01M b-glycerophosphate, and 108 M
dexamethasone] overnight. After 1 day, each scaffold was
seeded with 280,000 cells contained in 100 mL of complete
osteogenic media in accordance with previous studies.39,40
Three hours after cell seeding, 10mL of complete osteogenic
media was added to each well of a six-well plate. After 24 h
of attachment, the scaffolds were placed in new six-well
plates for 8, 16, and 21 days with complete osteogenic me-
dium. Media were changed every 3 days. Each group con-
sisted of n¼ 6 samples.
At the end of each culture period, samples were removed
from the cassettes and rinsedwith PBS solution. Three samples
from each groupwere stored at208C in ddH2O until analyses
were performed. One of the remaining three samples was im-
mersed in PBS with calcein-AM for 45min for observation
under confocal microscopy, and the other two samples were
fixed with 2.5% glutaraldehyde for Fourier transformed infra-
red spectroscopy (FTIR) analysis and for observation under
scanning electron microscopy (SEM).
DNA analysis
Measurement of the cell number in chitosan-based scaffolds
was assessed from cell lysates using the Picogreen dsDNA
Quantification Kit according to the instructions of the manu-
facturer (Molecular Probes, Eugene, OR). All standards and
samples were prepared in triplicate. The fluorescence at 545nm
was read on a plate reader (FLx800; Bio-Tek Instruments, Wi-
nooski, VT) to determine DNA concentrations per scaffold. The
cellularity of each scaffoldwas calculated by correlationwith the
DNA concentrationsmeasured from a knownnumber ofMSCs.
Alkaline phosphatase activity measurements
Alkaline phosphatase (ALP) activity assays were per-
formed on cell lysates using an established protocol.39 All
reagents were purchased from Sigma (St. Louis, MO). All
samples were prepared in triplicate and compared against p-
nitrophenol standards. The reaction was stopped by adding
100mL of 0.3N NaOH. Absorbance was read at 405 nm on a
plate reader (PowerWave 340; Bio-Tek) to determine the
ALP activity per scaffold.
Calcium deposition measurement
Calcium deposition measurements were made in tripli-
cate. CaP-coated chitosan-based scaffolds with incorporated
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lysozyme without cells at the end of each time period were
used as controls to determine the calcium content of the
coating. Then, these values were subtracted from the calcium
content obtained by CaP-coated chitosan-based scaffolds
with incorporated lysozyme cultured with cells to normalize
the data. Calcium deposition was evaluated using a calcium
assay from Diagnostic Chemicals (Oxford, CT). After ALP
and DNA assays were completed, a volume of 1N acetic acid
equal to the remaining volume was added to each well (for a
final concentration of 0.5N), and the plate was placed on an
orbital shaker overnight. A volume of 300 mL of calcium as-
say reagent was added to 20mL of sample solution in 96-well
plates. All samples were assessed in triplicate. To generate
a standard curve, serial dilutions of CaCl2 were prepared
(0–50 mg=mL). Absorbance was read at 650 nm with a spec-
trophotometer plate reader (PowerWave340; Bio-Tek). The
calcium deposition in each scaffold is reported as mg Ca2þ.
Microscopy analysis
After each time period, chitosan-based scaffolds were re-
moved from the cassettes, washed with PBS, and stained
with calcein-AM (Molecular Probes) according to the man-
ufacturer’s instructions. After 45min immersion in PBS with
calcein-AM, images were recorded using a laser scanning
confocal microscope with a 10 APO objective (Zeiss LSM
510 Axiovert; Carl Zeiss, Oberkochen, Germany). Samples
for SEM were washed twice in PBS and fixed with 2.5%
glutaraldehyde for 30min. Then, the scaffolds were washed
with PBS and dehydrated in a graded series of ethanol, and
dried after immersion in hexamethyldisilazane.
FTIR with attenuated total reflectance
Chitosan-based scaffolds before (control samples) and af-
ter 16 days of culture were analyzed by FTIR-attenuated total
reflectance (ATR). The scaffolds were fixed in 2.5% glutar-
aldehyde, dehydrated in a graded series of ethanol, and
dried at room temperature. All spectra were recorded using
64 scans and 4 cm1 in an FTIR spectrophotometer (IR
Prestige-21, Fourier Transformer infrared spectrophotome-
ter; Shimadzu, Kyoto, Japan).
Statistics
Results of DNA, ALP, and calcium assays are expressed as
mean standard deviation with n¼ 3 for each group. Sta-
tistically significant differences were determined using Stu-
dent’s t-test multiple comparison procedure at a confidence
interval of 95% ( p< 0.05).
Results and Discussion
Degradation studies
The degradation of chitosan in the human body has been
reported to be carried out by lysozyme.16,17 Previous studies
have identified the optimal concentration of lysozyme for the
degradation of chitosan-based scaffolds in vitro to be
1.5 g=L.33 Accordingly, a lysozyme concentration of 1.5 g=L
was used in the present study for optimal degradation of
the chitosan-based scaffolds, as well as to approximate the
FIG. 1. Weight loss of chitosan (Ch) scaffolds after 21 days
of immersion in PBS with lysozyme (1.5 g=L) solution.
Chitosan scaffolds were gradually degraded as a function of
time in lysozyme solution (1.5 g=L).
FIG. 2. Images of chitosan (Ch) scaffolds obtained by m-CT:
before degradation (A) and after 3 days (B), 7 days (C), 14
days (D), and 21 days (E) of degradation with lysozyme
(1.5 g=L). Lysozyme solution induced degradation and en-
hanced subsequent formation of pores in chitosan scaffolds
as a function of immersion time.
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FIG. 3. Porosity (A) and interconnectivity (B) of chitosan scaffolds as a function of immersion time with lysozyme (1.5 g=L).
Results are expressed as means standard deviation with n¼ 3 for each bar. Asterisk (*) indicates a significant difference
( p< 0.05) as a function of time compared with control samples. Immersion of chitosan scaffolds in lysozyme solution
increased the porosity and pore interconnectivity of the scaffolds with time.
FIG. 4. Pore size (A) and wall thickness (B) of chitosan scaffolds as a function of immersion time with lysozyme (1.5 g=L).
Results are expressed as means standard deviation with n¼ 3 for each bar. Asterisk (*) indicates a significant difference
( p< 0.05) as a function of time compared with control samples. Immersion of chitosan scaffolds in lysozyme solution
increased the mean pore size and decreased the mean pore wall thickness of the scaffolds with time.
FIG. 5. Laser scanning confocal microscope images of cells stained with calcein-AM at the top surface of scaffolds after 8
days: (A) chitosan (Ch), (B) CaP-coated chitosan scaffolds with incorporated lysozyme, (C) chitosan=starch (CS), and (D)
CaP-coated chitosan=starch scaffolds with incorporated lysozyme. All images obtained 45min after incubation with calcein-
AM using a 10 APO objective. The scale bar is 100 mm and applies to all images. Rat MSCs adhered to all scaffold
formulations and maintained viability after 8 days of culture, with no differences observed among the groups.
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concentration of similar enzymes previously incorporated into
biomimetic CaP coatings22 and the concentration of lyso-
zyme incorporated into the CaP coatings in the present
study.39,40 As observed in Figure 1, chitosan scaffolds were
degraded gradually as a function of immersion time in ly-
sozyme solution (1.5 g=L). The weight loss (%) after 3, 7, 14,
and 21 days was 11.6 0.5, 14.9 0.4, 15.6 0.4, and
18.2 1.1, respectively (Fig. 1). This gradual weight loss is
confirmed by images obtained by m-CT, where an almost
nonporous structure before degradation was observed
(Fig. 2A) with a significant increase in porosity after different
time periods, being obvious after 14 days (Fig. 2D) and 21
days (Fig. 2E). These results demonstrate the ability of ly-
sozyme to induce degradation and subsequent formation of
pores into chitosan scaffolds. Enzyme-independent starch
erosion might have contributed to the scaffold degradation
observed in the present study. Although minimal enzyme-
independent erosion was expected, the erosion of starch
from chitosan=starch scaffolds in the absence of lysozyme
was not examined in the present study and will be investi-
gated in future studies. As the present study established that
lysozyme in solution at a concentration similar to the con-
centration incorporated into the CaP coatings enhances pore
formation and interconnectivity with time, future studies
will examine the degradation of CaP-coated chitosan scaf-
folds with incorporated (i.e., entrapped) lysozyme.
Upon analyzing the images of chitosan (Ch) scaffolds
obtained by m-CT, it is possible to see the increase of porosity
as a function of immersion time (Fig. 2). The control scaffolds
(before degradation) presented *5% porosity. According to
Figure 3A lysozyme enhanced the porosity of the scaffolds as
a function of degradation time. After different time points,
lysozyme had a significant effect on chitosan scaffolds, in-
ducing the formation of a porous structure (Figs. 2 and 3A).
Further, the interconnectivity of chitosan scaffolds increased
significantly after 21 days (Fig. 3B). Moreover, the effect of
lysozyme was also detected in pore size and wall thickness
results (Fig. 4A, B), where a significant increase in size of
pores (Fig. 4A) and a significant decrease of wall thickness
(Fig. 4B) were evident compared with control scaffolds (be-
fore degradation). These results were expected since after
different periods of degradation with lysozyme the forma-
tion of pores was observed, evidencing a significant increase
of porosity as a function of degradation time *5–55% (Fig.
3A) up to 21 days, resulting in porous 3D structures with
interconnected pores (*78%). The observed increase in
scaffold porosity and pore interconnectivity could be due to
an increase in the size of existing pores, the formation of new
pores, or a combination of the two mechanisms. However,
the exact mechanism by which the scaffold porosity and pore
interconnectivity increased in the present study was not
elucidated.
Assays
Confocal microscopy images after 8 days show that rat
MSCs were able to adhere to all scaffold formulations and
maintain their viability. Cells covered the surface of all
scaffolds, and no differences can be observed among groups
(Fig. 5).
Scaffold cellularity is presented in Figure 6. It should be
noted that for cases in which cells were completely en-
trapped within ECM produced during culture, such that the
DNA therein could not be fully liberated for inclusion in the
lysate for assessment of cellularity, then the measured results
may reflect an underestimation of the actual number of cells
on=within the scaffold, especially at later time points.
However, an increase in cell number indicating cell prolif-
eration was observed between days 16 and 21 for all groups.
The number of cells after 8 days was lower than was ex-
pected, except for CaP-coated chitosan=starch with incorpo-
rated lysozyme. This can be related to the small surface area
of scaffolds where cells were seeded and explained by a lack
of initial porosity in these scaffolds. However, after 21 days,
a significant increase was observed in the number of cells for
CaP-coated chitosan scaffolds with incorporated lysozyme,
which corresponds to the increase in porosity as a function of
time, as was shown in the degradation results (Fig. 1).
During the time of culture with MSCs, it was expected that
lysozyme would be able to degrade CaP-coated chitosan-
based scaffolds, inducing the formation of pores by lysozyme
and allowing the penetration and colonization of cells into
the scaffolds, as shown in Figure 7B after 21 days.
The use of biomimetic coating methodology in this study
allowed the incorporation of lysozyme that will be able to
degrade chitosan-based scaffolds. It is expected that CaP
coatings will enhance the osteoconductive properties of the
resulting materials. The SEM images after 8 days show cells
attached to scaffold surfaces; however, after 16 and 21 days
all surfaces were completely colonized by the cells, and after
21 days mineralized matrix was observed on CaP-coated
chitosan-based scaffolds (Fig. 7A), clearly visible at high
magnifications for scaffolds with incorporated lysozyme
(Fig. 7B). These results corroborate the calcium content
measurements, where calcium was detected after 16 and 21
days (Fig. 8). Additionally, small pores were observed in the
dense layer for CaP=CSþ lysozyme at high magnifications
FIG. 6. Cellularity of chitosan-based scaffolds seeded with
MSCs after 8, 16, and 21 days. Results are expressed as
means standard deviation with n¼ 3 for each bar. Single
asterisk (*) indicates a significant difference ( p< 0.05) between
conditions at the same time point. Double asterisks (**) indi-
cate a significant difference ( p< 0.05) between different time
periods for each condition. An increase in cell number indi-
cating cell proliferation was observed between days 16 and 21
for all groups. Ch, chitosan scaffolds; CaP=Chþ lysozyme,
CaP-coated chitosan scaffolds with incorporated lysozyme;
CS, chitosan=starch scaffolds; CaP=CSþ lysozyme, CaP-
coated chitosan=starch scaffolds with incorporated lysozyme.
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FIG. 7. (A) SEM images of the surfaces of cultured chitosan-based scaffolds after 8, 16, and 21 days. The scale bar is 500mm and
applies to all images. Cells were visibly attached to scaffold surfaces for all groups after 8 days of culture, and the surfaces were
completely colonized by cells after 16 and 21 days. (B) SEM images of the surfaces of cultured chitosan-based scaffolds after 8, 16,
and 21 days. The scale bar is 100mmand applies to all images. These high-magnification images of the same groups represented in
(A) show mineralized matrix deposition on CaP-coated chitosan-based scaffolds with incorporated lysozyme.
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after 8 and 21 days. These pores seem to be induced by the
action of lysozyme present in CaP coatings (Fig. 7B).
ALP is an enzyme expressed by cells and is an early
marker of osteoblastic differentiation in MSCs.41 CaP=CSþ
lysozyme and uncoated scaffolds (Ch and CS) reached their
maximum measured ALP activity on day 8 and 16, respec-
tively (Fig. 9), reflecting the early osteogenic differentiation
stage of the MSCs. The highest value of ALP activity for
CaP=Chþ lysozyme was obtained at day 21; however, the
difference between the 16th and 21st days was not statisti-
cally significant.
Calcium deposition is an indicator of the level of mineral
deposition, which is a marker of the full maturation of os-
teoblastic cells. No calcified ECM deposition was observed at
day 8 (Fig. 8). After 16 days, calcium deposition was detected
for CaP-coated chitosan-based scaffolds with incorporated
lysozyme. At the end of the third week, the calcium mea-
surements indicated the deposition of significant amounts of
mineralized matrix for all scaffolds, with a significant in-
crease for CaP-coated chitosan-based scaffolds with incor-
porated lysozyme (Fig. 8). The amount of calcium detected
on CaP-coated scaffolds was higher for both time points of
CaP=Chþ lysozyme; however, when comparing cellularity
(Fig. 6), it is apparent that the number of cells was also
higher, indicating that the lower number of cells present in
CaP=CSþ lysozyme also was able to produce mineralized
ECM. Nevertheless, when comparing the number of cells
present in these two scaffolds with the calcium content, both
scaffolds had a similar effect on the cells. Indeed, comparison
of cellularity results (Fig. 6) and ALP activity results (Fig. 9)
reveals that the maximum ALP activity occurred at either
day 16 or 21 for all groups except the CaP=CSþ lysozyme
group. As ALP activity is an early marker of osteoblastic
differentiation of cells, and as cellular differentiation and
proliferation are inversely proportional, it follows that a
minimum in cellularity at day 16 may reasonably correspond
with a peak in ALP activity at day 16. Further, the presence
of mineralized matrix, as measured by calcium content of
constructs, increased with time for all groups, indicating the
osteogenic differentiation of cells in all groups, although this
effect was most pronounced in the CaP-coated scaffolds with
incorporated lysozyme.
FTIR with ATR
When FTIR-ATR spectra of controls (without cells) of
chitosan (Ch) and chitosan=starch (CS) scaffolds were ana-
lyzed, the characteristic bands of chitosan (1150–890 cm1)
were detected (Fig. 10A, C). After 16 and 21 days of culture
(Fig. 10A, C), these spectra showed the presence of amide
bands: 1650 cm1 (amide I) and 1542 cm1 (amide II), which
can be related to protein matrix formation. Carbonate groups
at 1500–1418 cm1 were also detected (Fig. 10A, B). These
carbonate groups are related to carbonate apatite, one of the
CaPs present in bone tissue, suggesting the presence of
mineralized ECM. Presented in Figure 10B and 10D are the
spectra of CaP=Ch with incorporated lysozyme and CaP=CS
with incorporated lysozyme scaffolds. In FTIR-ATR spectra
of the CaP-coated chitosan-based scaffolds when lysozyme
was incorporated, the presence of amide I and amide II in
uncultured scaffolds (controls) was detected (Fig. 10B, D).
The amide I band represents the stretching vibrations of
C¼O bonds in the backbone of the protein.42 Further, the
amide II band arises from the combination of C-N stretching
and N-H bending vibrations of the protein backbone.42 These
bands obtained in the case of the control samples could in-
dicate the adsorption of lysozyme on the surface of chitosan
and chitosan=starch scaffolds. However, an increase of in-
tensity of these bands was observed as a function of culture
time (Fig. 10B, D). As previously mentioned, these might
indicate a protein matrix formation. In the spectra of control
FIG. 8. Calcium content in chitosan-based scaffolds after
day 16 and day 21 culture periods. Results are expressed as
means standard deviation with n¼ 3 for each bar. Single
asterisk (*) indicates a significant difference ( p< 0.05) be-
tween conditions at the same time point. Double asterisks
(**) indicate a significant difference between days 16 and 21
for each condition. Calcium deposition increased with cul-
ture time for all groups, indicating the osteoblastic differen-
tiation of the MSCs cultured upon the scaffolds. Ch, chitosan
scaffolds; CaP=Chþ lysozyme, CaP-coated chitosan scaffolds
with incorporated lysozyme; CS, chitosan=starch scaf-
folds; CaP=CSþ lysozyme, CaP-coated chitosan=starch scaf-
folds with incorporated lysozyme.
FIG. 9. ALP activity of chitosan-based scaffolds seeded
with MSCs after 8, 16, and 21 days. Results are expressed as
means standard deviation with n¼ 3 for each bar. Single
asterisk (*) indicates a significant difference ( p< 0.05) be-
tween conditions at the same time point. Double asterisk (**)
indicates a significant difference ( p< 0.05) between 8, 16, and
21 days for each condition. CaP=CSþ lysozyme and un-
coated scaffolds (Ch and CS) reached their maximum mea-
sured ALP activity on day 8 and 16, respectively, reflecting
the early osteogenic differentiation stage of the MSCs.
Ch, chitosan scaffolds; CaP=Chþ lysozyme, CaP-coated
chitosan scaffolds with incorporated lysozyme; CS, chitosan=
starch scaffolds; CaP=CSþ lysozyme, CaP-coated chitosan=
starch scaffolds with incorporated lysozyme.
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scaffolds (Fig. 10B, D), carbonate bands (1500–1418 cm1)
were also detected, which are associated with CaP coating on
the surface of the scaffolds. In addition, these bands became
more intense with culture time, suggesting the formation
of mineralized ECM. However, phosphate bands (1190–
976 cm1) were not clearly detected, which was likely related
to overlapping with the polysaccharide ring band of chitosan
(1150–890 cm1).
FTIR-ATR results confirm the results of calcium measure-
ments, clearly suggesting protein matrix formation and the
presence of mineralized ECM. Further, these results suggest
that the mineral formed by rat MSCs cultured for 16 and 21
days is carbonate apatite mineral similar to the major mineral
component of bone. Future studies will build upon the results
from the present study, which demonstrates that lysozyme has
an effect on pore formation in chitosan scaffolds and osteogenic
differentiation ofMSCs, andwill focus upon the use of different
concentrations of lysozyme and characterization of the actual
lysozyme content of the scaffolds.
Conclusions
The degradation studies performed with lysozyme using
similar concentration to those incorporated into CaP coatings
showed the formation of pores as a function of immersion
time, indicating an increase of porosity *5–55% up to 21
days. Lysozyme had a significant effect on chitosan scaffolds
resulting in porous 3D structures with interconnected pores
(*78%). On the basis of these studies it was concluded
that CaP biomimetic coatings with incorporated lysozyme
FIG. 10. FTIR-ATR of chitosan (A), CaP=Chþ lysozyme (B), chitosan=starch (C), and CaP=CSþ lysozyme (D) scaffolds
before and after 16 and 21 days of culture with rat MSCs. Increases in the amide, carbonate, and phosphate bands indicate
increased deposition of mineralized ECM with time.
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enhance osteogenic differentiation of rat MSCs. Therefore,
the use of CaP biomimetic coating strategy with incorporated
lysozyme on the surface of chitosan-based scaffolds provides
an improved environment for rat MSC differentiation along
the osteogenic lineage when compared with uncoated scaf-
folds, as was shown by calcium deposition measurements
and FTIR-ATR results, indicating the production of miner-
alized ECM. The demonstrated ability of these novel surface-
coated scaffolds to form an interconnected pore structure
in situ coupled with the positive effect of these scaffolds on
the osteoblastic differentiation of MSCs and mineralized
matrix production clearly illustrate the strong potential of
these scaffolds for application in bone tissue engineering
strategies.
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